Microbot Medical, Inc. Common Stock
MBOTStock
$1.79−25.15%52W
Market Cap$119.89M
P/E—
Div yield—
Beta1.03
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-21.31%
Price vs S&P 500 (4W)1.60%
VGM Score32.50
Market Capitalization$119.89M
Earnings Surprise History
Q1 26-0.05est. -0.08
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.11
4.11
4.13
4.11
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MBOTMicrobot Medical, Inc. Common Stock | C | F | D | $1.79 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Microbot Medical develops robotic solutions for endovascular procedures, a minimally invasive approach to treating vascular conditions. The company's LIBERTY Endovascular Robotic System is a single-use, remotely operated platform designed to enhance precision and provider safety in vascular interventions. With a robust intellectual property portfolio, Microbot aims to establish a new standard in endovascular care delivery.